{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:42:01Z","timestamp":1770813721315,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Sobi","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hospital Practice"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/21548331.2025.2572958","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:14:11Z","timestamp":1760696051000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Real-world experience with pacritinib for patients with myelofibrosis refractory to ruxolitinib: a report of three cases"],"prefix":"10.1080","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6283-2754","authenticated-orcid":false,"given":"Mona","family":"Al-Rasheed","sequence":"first","affiliation":[{"name":"Adan Hospital MOH","place":["Hadiya, Kuwait"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9355-4114","authenticated-orcid":false,"given":"Sonia","family":"Otsmane","sequence":"additional","affiliation":[{"name":"Burjeel Medical City","place":["Abu Dhabi, UAE"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3130-7603","authenticated-orcid":false,"given":"Taghreed","family":"Al Essa","sequence":"additional","affiliation":[{"name":"Jahra Hospital","place":["Al Jahra, Kuwait"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6971-3020","authenticated-orcid":false,"given":"Mohammad","family":"Zureiqi","sequence":"additional","affiliation":[{"name":"Jahra Hospital","place":["Al Jahra, Kuwait"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S51800"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2006.12.002"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153904"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23690"},{"key":"e_1_3_4_6_1","volume-title":"Primary myelofibrosis","author":"Orphanet","year":"2019","unstructured":"Orphanet. Primary myelofibrosis. 2019. https:\/\/www.orpha.net\/en\/disease\/detail\/824"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-114416"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000452"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-11-395228"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2013.01.2628"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2023.2196593"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00392-1"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5818"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007524"},{"key":"e_1_3_4_15_1","volume-title":"Fda approves drug for adults with rare form of bone marrow disorder","author":"US Food and Drug Administration","year":"2022","unstructured":"US Food and Drug Administration. Fda approves drug for adults with rare form of bone marrow disorder. US Food and Drug Administration; 2022."},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/56.1.24"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010151"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.14321"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2022000340"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003314"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S110702"},{"key":"e_1_3_4_22_1","volume-title":"Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib in the United States. 2024 SOHO Annu Meet","author":"Marrone M","year":"2024","unstructured":"Marrone M, Geller R, Oladapo A, et al. Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib in the United States. 2024 SOHO Annu Meet. Houston (TX): Abstract MPN-497; 2024."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.7058"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/po.23.00234"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-1048"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16234064"}],"container-title":["Hospital Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21548331.2025.2572958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:30:14Z","timestamp":1770795014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21548331.2025.2572958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/21548331.2025.2572958"],"URL":"https:\/\/doi.org\/10.1080\/21548331.2025.2572958","relation":{},"ISSN":["2154-8331","2377-1003"],"issn-type":[{"value":"2154-8331","type":"print"},{"value":"2377-1003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihop20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ihop20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2572958"}}